New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 28, 2013
05:39 EDTHTGC, CTICCell Therapeutics secures $15M loan financing agreement with Hercules Technology
Cell Therapeutics (CTIC) announced it has entered into a loan agreement with Hercules Technology Growth Capital (HTGC) providing for a senior secured term loan of up to $15M. The first $10M of the term loan was funded at closing, and the remaining $5M is available at CTI's option at any time from November 30 through December 15, subject to the satisfaction of certain conditions.
News For CTIC;HTGC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 24, 2015
07:28 EDTHTGCHercules Technology 6.6M share Spot Secondary priced at $13.64
Wells Fargo, Raymond James and Keefe Bruyette acted as joint book running managers for the offering.
March 23, 2015
19:13 EDTHTGCOn The Fly: After Hours Movers
Subscribe for More Information
16:20 EDTHTGCHercules Technology files to sell 6.6M shares of common stock
Hercules expects to use the net proceeds from this offering to fund investments in debt and equity securities in accordance with its investment objective and for other general corporate purposes Wells Fargo Securities, Raymond James and Keefe, Bruyette & Woods, a Stifel Company, are acting as joint book-running managers in this offering.
March 17, 2015
12:38 EDTCTICCTI BioPharma management to meet with Piper Jaffray
Subscribe for More Information
March 16, 2015
15:15 EDTHTGCHercules Technology says EPS growth targets pushed out 'quarter or two'
"Our origination activity has been very robust as we continue to see healthy deal flow from our venture capital partners and from our innovative venture growth stage companies. However, we continue to see many of these new investments opportunities closing later and later in the quarter, thereby lowering our targeted intra-quarter weighted average loan balances, and pushing out our EPS growth targets by a quarter or two in the process. In addition, our forecasted early pay-offs, or prepayments, are materially lower than prior quarters and in-line with our expectations, which should allow us to grow our loan investment portfolio and begin to leverage our SG&A infrastructure investment in anticipation of higher year-end loan investment portfolio growth and balances. Finally, we continue to selectively pursue new loan investment opportunities that meet our credit underwriting standards, as we look to systematically grow our loan investment portfolio to new records levels in 2015 with senior secured high quality investments. We remain steadfast in not trading-off increased credit risk in the quest for higher loan yields by reaching down the capital structure, and prefer to accept lower loan yields in lieu of increased credit risk," said Hercules chairman and CEO Henriquez.
15:14 EDTHTGCHercules Technology reports Q1 closed commitments to date near $170M
Subscribe for More Information
09:15 EDTCTICCTI BioPharma shares should be bought on weakness, says Roth Capital
Subscribe for More Information
05:27 EDTCTICCTI BioPharma announces publication of Phase 2 pacritinib study results
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use